# Q500B verification review: s87 revised, Decreased level of consciousness (loc)

Reviewer: Preceptor QA, fresh and independent. I did not write, edit or review this batch before. File reviewed: `src/samps/s87/loc.ts`, ids loc-48 to loc-52, the whole final batch. No edits were made to the batch (REVIEW-RULES rule 1).

Read first: `docs/Q500B_BRIEF.md` (Independent QA), `docs/reviews/REVIEW-RULES.md`, `docs/reviews/SCORING-RULINGS.md`, `docs/SAMP_REVIEW_BRIEF.md`, the first review `docs/reviews/q500b-qa-s87.md` and the writer report `docs/reviews/q500b-writer-s87.md` with its "Revision 1" section.

## Tests

`SAMP_BATCH=s87 npx vitest run tests/samps.test.ts tests/samp-quality.test.ts tests/citations.test.ts --testTimeout=120000`: 3 files, 128 tests passed, the bank-wide near-duplicate stem test included (5.5 s).

## First-review fails: are they resolved?

| First-review item | Resolved? | Note |
|---|---|---|
| loc-48 q2 mock cue | Yes | Update no longer names the log or guard. |
| loc-48 q4 near-duplicate of loc-07 q2 | Yes | Now the destination decision. No "until sober" or skull X-ray distractors. Distinct from multiple-trauma (s45, call neurosurgery after CT shows a growing subdural), ems (s09, calls after CT shows an epidural) and environmental (s36, medevac to an ECLS centre). |
| loc-49 q3 near-duplicate of shock-14 | Yes | Hypernatremia, heat wave and shock are gone. Phenobarbital toxicity is not in the bank as a scenario or key (grep: phenobarbital appears only as a seizure or withdrawal drug, and in neonatal jaundice and HIE distractors). New fails on the rebuilt q3 and q4 below. |
| loc-49 q4 mock cue | The named cue is gone | The update does not name the q3 key, but the new option set implies it (see below). |
| loc-50 q3 duplicate of loc-18 q4 | Yes | Now a KF5 trending question. No pediatric GCS descriptors. Kleizen supports fluctuating consciousness. |
| loc-51 q1 and q2 repeat of loc-24 q4 | Diphenhydramine twist removed | Diphenhydramine, physostigmine and Dawson are gone, and no question keys CT now or neurosurgery. The new migraine twist repeats a headache-bank template (see below). |
| loc-51 q4 (now q3) mock cue | Yes | "When stimulated again" no longer narrows q2 to the central options. |
| loc-52 stem and q1 duplicate of suicide-risk s52 | Yes | The Dari-speaking family, child interpreter and low mood are gone. Karliner is dropped. The q3 update takes the cancer and transplant history from the provincial record and does not name the q1 key. |

## Sources verified

Fetched by curl because WebFetch returned 503 for Europe PMC.

- Proudfoot 2004, PMID 15083932 (Europe PMC abstract): "Urine alkalinization cannot be recommended as first line treatment in cases of phenobarbital poisoning as multiple-dose activated charcoal is superior", and "urine pH manipulation rather than a diuresis is the prime objective". This supports loc-49 q4.
- Edlow 2014, PMID 24767707 (abstract): the three mechanisms, including "rarely, psychiatric causes". History, examination and laboratory findings are used to find structural causes. "Imaging should be done in post-traumatic coma or when structural brain lesions are probable or possible causes". Checklist includes "treatable poisoning". This supports 48 q1, 49 q1 and q3, 50 q2, 51 q4, 52 q1 and q2.
- Jones 2010, PMID 20304569 (abstract): 10 to 15 mg/100 mL/h fasted, 15 to 20 non-fasted, 25 to 35 "in alcoholics during detoxification". The loc-48 q2 wording "10 to 20" and "heavy drinkers" is a fair summary.
- Kleizen 2009, PMID 19673722 (abstract): 10 of 58 (17%), lethargy, then hypotonia and fluctuating consciousness. This supports 50 q1 and q3.
- BTF 2023, PMC10627685: GCS before sedative or paralytic agents (Strong), pupils recorded and relayed (Strong), moderate to severe TBI "transported directly to a facility with immediately available CT neuroimaging capabilities, prompt neurosurgical care, and the ability to monitor intracranial pressure" (Strong). A stop at a nontrauma centre only "in the event that this transport is not possible" (Weak). This supports 48 q3 and q4 as written.
- ICHD-3 1.1, ichd-3.org: criteria C and D. The note on falling asleep during an attack and criterion E were read. D is "nausea and/or vomiting" or "photophobia and phonophobia" (both, not photophobia alone).
- GCS aid, glasgowcomascale.org/gcs-aid: fingernail stimulus peripheral, trapezius and supraorbital central, "Stimulation by rubbing the knuckles on the sternum is strongly discouraged". This supports loc-51 q2.
- GCS FAQ, glasgowcomascale.org/faq: "Do not use number '1' to record missing component; use 'NT'". No total when a component is NT. "Intellectual or neurological deficit" is listed as a pre-existing interfering factor. This supports loc-49 q2.
- Not re-opened, unchanged and verified by the first review: Lin-Martore 2020 (PMC7390574), ISTH GPS 2020 (PMC7880820), PLASMIC on the MSD calculator. I opened no source that I could not verify.

## Bank-wide repeat search

Searched all of `src/samps` and `src/cases`. Terms: phenobarbital, multiple-dose or multiple dose charcoal, MDAC, urine or urinary alkalinization, posterior fossa, cerebellar, migraine (usual, typical, sleep it off), trapezius, PLASMIC, ADAMTS13, intussusception, neurosurgical centre, fly-in, group home, night shift and destination prompts.

- Multiple-dose charcoal is keyed in tox-20 (carbamazepine), in the theophylline and amatoxin SAMPs (s53) and is a distractor in s83 and the baclofen SAMP. loc-49 q4 applies it to a different drug and a chronic dosing error, which is acceptable. The urinary alkalinization distractor recurs, but the teaching point (MDAC is superior for phenobarbital, and pH rather than diuresis) is specific.
- Posterior fossa or cerebellar: loc-09 (write-in differential), cva s05 (swelling cerebellar infarct), cva s27 (cerebellar ICH on dabigatran: imaging, reversal, consult) and headache s40 (cough headache, pediatric tumour). None keys "posterior fossa stroke" as the most likely cause after a false minor attribution, so loc-51 q4 is acceptable.
- Migraine mimics: headache-50 q1 (`src/samps/s75/headache.ts`) has the same decision template and distractor family as the new loc-51 q1. That item fails below. headache-18 q1, headache-42 q1 and headache-49 q1 are related red-flag items with different keys.
- TTP: s32 has TTP only as a porphyria distractor, and s15 and s47 cover pregnancy. loc-52 is acceptable.
- Intussusception: loc-50 q4 (POCUS) shares the ultrasound-first point with an abdominal-pain SAMP in s01 and one in s19. Its distractors (CT head, LP, drug screen) carry the loc-specific trap, and the first review passed it. I note it but do not fail it.
- Collateral-source questions: four of the five SAMPs have a "which source best" KF3 question (48 q1, 49 q1, 50 q2, 52 q1). Each has a distinct context and passed review. This is a low-concern sameness inside the batch, not a defect.

## Verdicts

### loc-48 Could not be woken for breakfast

Numbers: E2 V2 M4 = 8. Pulse 56 with BP 174/98 is used consistently.

| Q | Verdict | Finding and exact fix |
|---|---|---|
| q1 | PASS | |
| q2 | PASS | First-review fix applied. The update does not name the log or the guard. |
| q3 | PASS | BTF verified. |
| q4 | PASS | Rebuilt as asked. The key is supported by the BTF Strong recommendation, and the explanation states the Weak exception correctly. The q3 update "before the flight out" leads into q4 in normal order, which is not a B6 defect. |

### loc-49 Less responsive at the group home

Numbers: E2 V NT M5. "Total GCS 8 with V1" = 2 + 1 + 5 = 8, correct. 30 mg twice daily plus 60 mg twice daily = 180 mg/day (3.9 mg/kg/day at 46 kg).

| Q | Verdict | Finding and exact fix |
|---|---|---|
| q1 | PASS | Unchanged. |
| q2 | PASS | Unchanged. NT is supported by the FAQ (writer uncertainty 3 from the first round). |
| q3 | FAIL (low) | The explanation says "180 mg of phenobarbital a day instead of the 120 mg ordered", but the update never gives the ordered dose or says the new tablets replaced the old ones. Fix: reword the update to "It holds his old phenobarbital 30 mg tablets and the new 60 mg tablets his neurologist ordered twice daily 10 days ago to replace them, and both are signed as given twice daily since then." No other change is needed. Writer uncertainty 2 (hypothermia and slow breathing in barbiturate toxicity) is standard toxicology used as supporting reasoning only, and is acceptable. |
| q4 | FAIL (medium) | (1) Mock-mode cue (ruling B6). All five options are poisoning treatments (flumazenil, forced diuresis, MDAC, single-dose charcoal, urinary alkalinization), and alkalinization with MDAC is the classic phenobarbital pair. Shown at once, they rule out every q3 distractor (hyperammonemia, NCSE, subdural, urosepsis) and give away "Phenobarbital toxicity". The question can work without this, so B6 requires a fix, not a flag. Fix: keep "Multiple-dose activated charcoal" (key) and "Urinary alkalinization". Replace the other three with one treatment for each q3 distractor, at the same level of detail. Example set: "Ceftriaxone IV", "Lactulose by gastrostomy", "Levetiracetam IV load", "Multiple-dose activated charcoal", "Urinary alkalinization". Rewrite the distractor sentences to match (the stem gives no infection, liver disease or valproate, NCSE is unlikely on extra anticonvulsant, and alkalinization is inferior to MDAC per Proudfoot). Re-key the index after alphabetical ordering. (2) Airway safety (writer uncertainty 1, which I uphold). The stem says he "coughs weakly when suctioned", and the explanation says the airway must be protected "if his cough weakens", which reads as if it is not already weak. MDAC needs a protected airway. Fix: change the q4 update to "He breathes 10/minute with a saturation of 95% on 2 L/minute by nasal prongs. His cough and gag are now strong, and he is nursed with the head of the bed at 30 degrees. His blood pressure is stable." Change the explanation clause to "and his airway must be reassessed before each dose." |

### loc-50 Collected early from daycare

| Q | Verdict | Finding and exact fix |
|---|---|---|
| q1 | PASS | |
| q2 | PASS | |
| q3 | PASS | Rebuilt as asked. Kleizen supports fluctuating consciousness. The father's "tests can be cancelled" implies investigations are under way, but "Oral rehydration trial before tests" also leads to tests, and q4's own prompt implies investigation, so this is not a B6 defect. The key is the longest option (35 against 33 characters) but is not the only plausible-length option. Low concern. |
| q4 | PASS | Unchanged. See the overlap note on ultrasound for intussusception. |

### loc-51 Sleeping it off, says his wife

Numbers: q3 E2 V2 M5 = 9. Distractor sums correct (E1 V2 M4 = 7, E2 V2 M4 = 8, E2 V3 M5 = 10, E3 V2 M5 = 10). The timeline (1000 onset, 1230 arrival, 1300 metoclopramide, 1530 decline, q2 then q3 ten minutes later) is consistent. The title change from the first draft is an unrequested change. I judge it on its merits (rule 4): it is fine.

| Q | Verdict | Finding and exact fix |
|---|---|---|
| q1 | FAIL (medium) | (1) Near-duplicate template of headache-50 q1 (`src/samps/s75/headache.ts`): a known migraineur, "which finding shows this needs more than migraine treatment", with the distractors drawn from the ICHD-3 migraine criteria. Light sensitivity, nausea and vomiting, and throbbing pain against "Light and sound sensitivity", "Nausea through the attack" and "Throbbing on one side". Only the red-flag key differs. The red-flag-versus-migraine-features point is also taught in headache-42 q1 and headache-49 q1. (2) Grammar cue (B4): "Unable to walk without help" is the only adjective phrase among noun phrases. (3) The explanation says ICHD-3 lists "photophobia" as a migraine feature. Criterion D is photophobia and phonophobia together. Fix: keep KF4 and the wife's "sleep it off" attribution, but rebuild q1 so that the tested finding is about his drowsiness, not his headache, and the distractors are not the ICHD-3 headache criteria. For example: prompt "Which of the following findings at 1530 most strongly indicates that his drowsiness is not the sleep that follows his migraines?", key "Confused when roused to voice", distractors "Asleep 2 hours after an antiemetic", "Eyes closed in a darkened room", "Hours of sleep after past attacks", "No vomiting since 1300" (alphabetical, key index 1). Cite a passage that supports the key, for example the ICHD-3 note that sleep ends the attack (the patient "wakes up without it"), so a patient who wakes confused has more than migraine. If a migraine criterion is quoted anywhere, write "photophobia and phonophobia". |
| q2 | PASS | The stimulus question moved from q3. Supported by the GCS aid. |
| q3 | PASS | First-review cue fixed. The explanation's "central stimulus" is consistent with "brings his hand up past his chin toward the stimulus". |
| q4 | PASS | Edlow supports the structural-cause and imaging point. Writer uncertainty 3: "Posterior fossa stroke" covering both hemorrhage and swollen infarct is acceptable, because stroke includes intracerebral hemorrhage and the two cannot be told apart without imaging. All distractor reasons are true. |

### loc-52 Confused at the start of a night shift

PLASMIC recomputed: 7 of 7 (platelets 12, hemolysis, no cancer, no transplant, MCV 86, INR 1.1, creatinine 118 umol/L below 177). Menu q4 correct indexes [3, 4] = methylprednisolone and plasma exchange, correct.

| Q | Verdict | Finding and exact fix |
|---|---|---|
| stem | PASS | Rewritten as asked. No reuse of the s52 suicide-risk scenario. |
| q1 | PASS | New KF3 angle, last-well from the person she lives with. Supported by Edlow (history first). |
| q2 | PASS | The stress label is kept in the clinic note as the first review advised. |
| q3 | PASS | |
| q4 | PASS | Mixed option set (eculizumab, IVIG, heparin, vitamin K, tranexamic acid), so it does not cue q3. The ISTH statements were verified in the first review. |

## Writer's Revision 1 uncertainties

1. loc-49 q4 MDAC through a gastrostomy with a weak cough: upheld as a defect. The fix is in loc-49 q4 above.
2. loc-49 q3 hypothermia and slow breathing unsourced: acceptable as supporting reasoning. It is standard barbiturate toxicology and not the basis of the key.
3. loc-51 q4 "Posterior fossa stroke": acceptable.

## House style and format

No em or en dashes and no semicolons in strings. Canadian spelling ("behaviour", "centre", "localizes"). No mnemonics, no personal names. Author "Preceptor", `reviewed: false`, `version: 1`. Options alphabetical. Generic drug names are lower case per SAMP_SPEC ("flumazenil 0.2 mg IV"). It is the only option in its set with a dose, which does not cue the key, and it is removed by the loc-49 q4 fix anyway. No contradiction of SCORING-RULINGS found. These are MCQ items, so the A rules do not apply. B1, B4 and B6 were checked.

## Key feature coverage after the fixes

KF1 5, KF2 2 (loc-49 q4, loc-52 q4), KF3 4, KF4 4, KF5 5. The fixes keep every tag.

## Summary

5 SAMPs, 20 questions. All 10 first-review fails are resolved as asked. 17 questions pass. 3 fail: loc-49 q3 (low, explanation dose claim not in the update), loc-49 q4 (medium, mock-mode cue from an all-poisoning option set plus airway statement), and loc-51 q1 (medium, repeats the headache-50 q1 template and distractor family, plus a grammar cue and an ICHD-3 wording slip). No numeric, score or dose errors. Every citation I opened exists and supports its point.

Overall: FAIL (3 items)
